Literature DB >> 2304789

Acute mental status changes in children with systemic cancer.

F J DiMario1, R J Packer.   

Abstract

Acute changes in mental status (AMS) develop in children with cancer from a multitude of cancer- and treatment-related complications. To determine the incidence, etiology, and outcome of children with cancer who had AMS, the medical records of all children under 18 years of age with systemic cancer (excluding primary central nervous system tumors) who had AMS in our institution during the years 1981 through 1987 were reviewed. AMS developed in 89 of 815 children at risk (11%). The AMS was caused by seizures in 53 (60%), an encephalopathy in 24 (27%), and a stroke syndrome in 12 (13%). AMS occurred in 42 of 305 (14%) with leukemia, 16 of 139 (12%) with lymphoma, 14 of 136 (10%) with sarcoma, 10 of 104 (9%) with neuroblastoma, and 7 of 104 (5%) with other malignancies. Children with acute lymphocytic leukemia were more prone to having seizures (61%), while children with nonacute lymphocytic leukemia were almost equally likely to have encephalopathies, strokes, or seizures. Children with lymphoma were admitted for treatment most often with an encephalopathy (44%). Etiologies for AMS were evaluated vigorously, and one or more etiologies were identified in 80 of 89 (89%) patients. Dependent on the type of tumor, the anticancer treatment used and, timing during the course of illness AMS occurred, specific diagnoses were more likely. Neurologic morbidity and mortality were dependent on the cause of AMS. Children with seizures that were initially difficult to control were more likely to require long-term anticonvulsant therapy.

Entities:  

Mesh:

Year:  1990        PMID: 2304789

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

1.  Diagnostic Clues to Human Herpesvirus 6 Encephalitis and Wernicke Encephalopathy After Pediatric Hematopoietic Cell Transplantation.

Authors:  Zsila Sadighi; Noah D Sabin; Randall Hayden; Elizabeth Stewart; Asha Pillai
Journal:  J Child Neurol       Date:  2015-01-06       Impact factor: 1.987

Review 2.  Neurologic complications of chemotherapy for children with cancer.

Authors:  Alyssa T Reddy; Kerry Witek
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

3.  Chemotherapy related fatal neurotoxicity during induction in acute lymphoblastic leukemia.

Authors:  Munni Ray; R K Marwaha; Amita Trehan
Journal:  Indian J Pediatr       Date:  2002-02       Impact factor: 1.967

Review 4.  Quantitative morphologic evaluation of magnetic resonance imaging during and after treatment of childhood leukemia.

Authors:  Wilburn E Reddick; Fred H Laningham; John O Glass; Ching-Hon Pui
Journal:  Neuroradiology       Date:  2007-07-26       Impact factor: 2.804

Review 5.  Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment.

Authors:  Gagandeep Singh; Jeremy H Rees; Josemir W Sander
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04       Impact factor: 10.154

6.  Hemorrhagic and ischemic stroke in children with cancer.

Authors:  Corina Noje; Kenneth Cohen; Lori C Jordan
Journal:  Pediatr Neurol       Date:  2013-08-12       Impact factor: 3.372

7.  Stroke in Middle Eastern children with cancer: prevalence and risk factors.

Authors:  Catherina Zadeh; Natally AlArab; Samar Muwakkit; Lamya A Atweh; Hani Tamim; Maha Makki; Hamza A Salhab; Roula Hourani
Journal:  BMC Neurol       Date:  2022-01-18       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.